Your Most Trusted Partner Since 1946

The Next-Generation Varicella Vaccine.

Setting a new standard in seroconversion protection with up to 98.2% seroconversion rates.

Engineered with advanced 2X Trehalose technology in a convenient Pre-Filled Syringe (PFS).

Nexipox Plus Vaccine Pack Insert

Explore Efficacy Data

The Clinical Burden of Chickenpox

Varicella-Zoster Virus (VZV) remains a highly contagious disease with potential for severe complications across all age groups.

High Transmission

VZV has a secondary attack rate of up to 90% in susceptible household contacts, making it among the most contagious infectious diseases known to medicine.

Severe Complications

Risks include secondary bacterial infections, pneumonia, and central nervous system manifestations including encephalitis and cerebellar ataxia.

Vulnerable Populations

Increased risk of severe morbidity in immunocompromised patients, pregnant women, and neonates, requiring heightened clinical vigilance and early intervention.

Advanced Formulation for Uncompromised Potency

Varicella-Zoster Virus (VZV) remains a highly contagious disease with potential for severe complications across all age groups.

Patented Technology,2X Trehalose

Patented in 158 countries;Double Trehalose acts as a superior cryoprotectant and thermo-stabilizer, ensuring the live attenuated virus maintains peak viability during manufacturing, storage and transport which enables a near 100% antigenic delivery to patients.

Highest Effectiveness,98.2% Seroconversion

Clinically demonstrated in India’s largest clinical trial for varicella vaccine with a result of 98.2% seroconversion and 35.4 times higher GMFR providing superior immunogenicity and long-lasting protection against chickenpox disease.

Gelatin-Free,Best in class Safety

Gelatin free vaccine minimizes the risk of severe allergic reactions associated with traditional vaccine stabilizers resulting in 0 Serious adverse events and 0% Breakthrough with 2 doses

Patient Resources & Guidelines

Paediatric Schedule

Pregnancy Guidelines

Existing Conditions

FAQs and Aftercare

Administration & PFS Advantage

The Pre-Filled Syringe (PFS) format eliminates reconstitution errors, reduces preparation time by 40%, and ensures precise dosage administration. Subcutaneous (SC) injection.

Nexipox Room

No articles available.

Know More